High levels of genomic aberrations in serous ovarian cancers are associated with better survival
Files
(Published version)
Date
2013
Authors
Baumbusch, L.
Helland, Å.
Wang, Y.
Liestøl, K.
Schaner, M.
Holm, R.
Etemadmoghadam, D.
Alsop, K.
Brown, P.
Australian Ovarian Cancer Study Group,
Editors
Bishop, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
PLoS ONE, 2013; 8(1):e54356-1-e54356-8
Statement of Responsibility
Lars O. Baumbusch, Åslaug Helland, Yun Wang, Knut Liestøl, Marci E. Schaner, Ruth Holm, Dariush Etemadmoghadam, Kathryn Alsop, Pat Brown, Australian Ovarian Cancer Study Group, Gillian Mitchell, Sian Fereday, Anna DeFazio, David D. L. Bowtell, Gunnar B. Kristensen, Ole Christian Lingjærde, Anne-Lise Børresen-Dale
Conference Name
Abstract
Genomic instability and copy number alterations in cancer are generally associated with poor prognosis; however, recent studies have suggested that extreme levels of genomic aberrations may be beneficial for the survival outcome for patients with specific tumour types. We investigated the extent of genomic instability in predominantly high-grade serous ovarian cancers (SOC) using two independent datasets, generated in Norway (n = 74) and Australia (n = 70), respectively. Genomic instability was quantified by the Total Aberration Index (TAI), a measure of the abundance and genomic size of copy number changes in a tumour. In the Norwegian cohort, patients with TAI above the median revealed significantly prolonged overall survival (p<0.001) and progression-free survival (p<0.05). In the Australian cohort, patients with above median TAI showed prolonged overall survival (p<0.05) and moderately, but not significantly, prolonged progression-free survival. Results were confirmed by univariate and multivariate Cox regression analyses with TAI as a continuous variable. Our results provide further evidence supporting an association between high level of genomic instability and prolonged survival of high-grade SOC patients, possibly as disturbed genome integrity may lead to increased sensitivity to chemotherapeutic agents.
School/Discipline
Dissertation Note
Provenance
Description
Martin K Oehler is a member of the Australian Ovarian Cancer Study Group
Access Status
Rights
© 2013 Baumbusch et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.